Published November, 2010
By Judith E. Karp
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 1.00
Availability: Available

This is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities.

---

Published November, 2010
By Guy B. Faguet and Guy Faguet
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 1.00
Availability: Available

A comprehensive and critical review of the latest scientific advances in our understanding of the molecular genetics and biology of CLL and their application to the best management of CLL.

---

Published November, 2010
By Reinhold Munker, Erhard Hiller, Jonathan Glass and Ronald Paquette
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 1.00
Availability: Available

Now in its second edition, Modern Hematology: Biology and Clinical Management reflects the major advances in the understanding, diagnosis, and treatment of blood disorders. In 23 chapters, all major blood diseases are covered, as well as rare diseases that are of scientific interest.

---

Published October, 2010
By Ayalew Tefferi and Srdan Verstovsek
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 1.00
Availability: Available

This succinct resource provides an ideal balance of the biology and practical therapeutic strategies for classic and non-classic BCR-ABL-negative myeloproliferative neoplasms.

---

Published June, 2010
By S. Vincent Rajkumar, Morie A. Gertz and S.Vincent Rajkumar
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 2.00
Availability: Available

An up-to-date reference on this fascinating set of complex disorders, this book features the most comprehensive strategies for diagnosing, classifying, imaging, treating, and managing amyloidosis in multiple organ systems.

---

Published March, 2010
By Hillard M. Lazarus and Mary J. Laughlin
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 1.00
Availability: Available

Since the original publication of Allogeneic Stem Cell Transplantation: Clinical Research and Practice, Allogeneic hematopoietic stem cell transplantation (HSC) has undergone several fast-paced changes.

---

Published January, 2010
By Dan Jones
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 5.00
Availability: Available

This text on hematopathology integrates clinical and experimental studies with diagnostic criteria. It connects the field with recent advances in immunology research and includes coverage of myeloid, lymphoid tumors and transplant biology.

---

Published December, 2009
By Michael Kleinberg
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 1.00
Availability: Available

In Managing Infections in Patients with Hematological Malignancies, the authors and editor draw on their extensive expertise while providing a roadmap for hematologists to efficiently manage the complex infections within their patients.

---

Published November, 2008
By Sagar Lonial
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 5.00
Availability: Available

Partnerships between academic institutions, the pharmaceutical industry, patient advocacy groups, the National Cancer Institute, community onco- gists, and ultimately our patients worked closely together to realize these advances, and to effect the radical changes in therapy we have witnessed over the past few years.

---

Published November, 2008
By Robert J. Soiffer
Publisher: Springer (Humana Press Inc.)
Series: Contemporary Hematology
Rating: 1.00
Availability: Available

Remarkable developments in the field of transplantation have created opportunities to address the formidable challenges of transplantation across histocompatibility barriers, stem cell expansion, and prevention of complications and generation of graft-vs-tumor activity to eradicate residual disease.

---